Objective. Frequent monitoring of haemoglobin concentration is highly recommended by physicians to diagnose anaemia and polycythemia vera. Moreover, other conditions that also demand assessment of haemoglobin are blood loss, before blood donation, during pregnancy, and preoperative, perioperative and postoperative conditions. The cyanmethemoglobin/haemiglobincyanide method, portable haemoglobinometers and haematology analyzers are some of the standard methods used to diagnose the aforementioned ailments. However, discomfort, delay and risk of infection are typical limitations of traditional measuring solutions. These limitations create the necessity to develop a non-invasive haemoglobin monitoring technique for a better lifestyle. Approach. Various methods and products have already been developed and are popular due to their non-invasiveness; however, invasive solutions are still considered as the reference standard method. Therefore, this review summarizes the attributes of existing non-invasive solutions. These attributes are finalized as brief details, accuracy, optimal benefits and research challenges for exploring potential gaps, advancements and possibilities to consider as futuristic alternative methodologies. Main results. Non-invasive total haemoglobin assessment techniques are mainly based on optical spectroscopy (reflectance/transmittance) or digital photography, or spectroscopic imaging in spot-check/continuous monitoring mode. In all these techniques, we have noticed that there is a need to consider different light conditions, motion artefacts, melanocytes, other blood constituents, smoking and precise fixing of the sensor from the sensing spot for exact formulation. Significance. Moreover, based on careful and critical analysis of outcomes, none of these techniques or products are used independently or intended to replace invasive laboratory testing. Therefore, there is a requirement for a more accurate technique that can eliminate the requirement for blood samples and likely end up as a reference standard method.
Background: Hemoglobin is an essential biomolecule for the transportation of oxygen, therefore, its assessment is also important to be done frequently in numerous clinical practices. Traditional invasive techniques have concomitant shortcomings, such as time delay, the onset of infections, and discomfort, which necessitate a non-invasive hemoglobin estimation solution to get rid of these constraints in health informatics. Currently, various techniques are underway in the allied domain, and scanty products are also feasible in the market. However, due to the low satisfaction rate, invasive solutions are still assumed as the gold standard. Recently introduced technologies effectively evolved as optical spectroscopy and digital photographic concepts on different sensing spots, e.g., fingertip, palpebral conjunctiva, bulbar conjunctiva, and fingernail. Productive sensors develop more than eight wavelengths to compute hemoglobin concentration and four wavelengths to display only Hb-index (trending of hemoglobin) either in disposable adhesive or reusable cliptype sensor’s configuration. Objective: This study aims at an optimistic optical spectroscopic technique to measure hemoglobin concentration and conditional usability of non-invasive blood parameters’ diagnostics at point-ofcare. Methods: Two distinguishable light emitting sources (810 nm and 1300 nm) are utilized at isosbestic points with a single photodetector (800-1700 nm). With this purpose, reusable finger probe assembly is facilitated in transmittance mode based on the newly offered sliding mechanism to block ambient light. Results: Investigation with proposed design presents correlation coefficients between reference hemoglobin and every individual feature, a multivariate linear regression model for highly correlated independent features. Moreover, principal component analytical model with multivariate linear regression offers mean bias of 0.036 and -0.316 g/dL, precision of 0.878 and 0.838 and limits of agreement from -1.685 to 1.758 g/dL and -1.790 to 1.474 g/dL for 18 and 21 principal components, respectively. Conclusion: The encouraging readouts emphasize favorable precision; therefore, it is proposed that the sensing system is amenable to assess hemoglobin in settings with limited resources and strengthening future routes for the point of care applications.
Background/Objectives: Medical research institutions are increasingly leveraging artificial intelligence (AI) to enhance the processing and analysis of medical imaging data. However, scaling AI-driven medical image analysis often requires specialized expertise and infrastructure that individual labs may lack. A centralized solution is to establish a core facility—a shared institutional resource—dedicated to Automated Medical Image Processing and Analysis (AMIPA). Methods: This technical note offers a practical roadmap for institutions to create an AI-based core facility for AMIPA, drawing on our experience in building such a resource. Results: We outline the key components for replicating a successful AMIPA core facility, including high-performance computing resources, robust AI software pipelines, data management strategies, and dedicated support personnel. Emphasis is placed on workflow automation and reproducibility, ensuring researchers can efficiently and consistently process large imaging datasets. Conclusions: By following this roadmap, institutions can accelerate AI adoption in imaging workflows and foster a shared resource that enhances the quality and productivity of medical imaging research.
Background: Brain metastases (BMs) patients often receive multiple courses of radiotherapy (RT). Comparing follow-up imaging with RT plans is time-intensive and currently not possible in picture archiving and communication system (PACS). In this study, we aim to develop an automated tool to overlay pre-RT tumor contours onto follow-up MRI in the PACS to support response assessment and identification of untreated metastases, reducing review complexity and time. Methods: We built an AI-driven workflow that registers planning CT to follow-up MRI and propagates treated-lesion contours; outputs are exported as PACS-compliant DICOM. Performance was evaluated in 40 patients: 20 underwent quantitative comparison between manual and automated registrations using Dice similarity coefficient (DSC) and mean surface distance (MSD), following AAPM TG-132 guidelines; 20 additional patients (5-35 lesions per patient) underwent clinical evaluation of follow-up and pre-RT lesions contours visualization in PACS. Three physicians assessed these cases to measure review time and inter-observer agreement in treatment response classification (improved/stable vs indeterminate). Results: The workflow successfully registered all CT-MRI pairs. Mean DSC/MSD was: brain 0.97 ± 0.01/0.0 ± 0.0 mm, brainstem 0.89 ± 0.03/0.1 ± 0.1 mm, and gross tumor volumes 0.65 ± 0.18/0.6 ± 0.4 mm. Average physician review time per case decreased from 7.97 to 3.95 min with the automated workflow, and full inter-physician agreement increased from 72.4% to 93.5%. Conclusion: We developed and validated an AI-based tool that accurately fuses pre-RT contours with follow-up MRI for BMs, addressing a key gap in current PACS systems. The workflow significantly reduced review time per lesion and enhanced inter-physician agreement, and has the potential to enable faster, more consistent multidisciplinary follow-up assessment.
Background: Non-invasive bio-diagnostics are essential for providing patients with safer treatment. In this subject, significant growth is attained for noninvasive anaemia detection in terms of Hb concentration by means of spectroscopic and image analysis. The lower satisfaction rate is found due to inconsistent results in various patient settings. Objective:: This observational study aims to present an adaptable point-of-care Near-Infrared (NIR) spectrophotometric approach with a constructive Machine Learning (ML) algorithm for monitoring Haemoglobin (Hb) concentration by considering dominating influencing factors into account. Methods:: To accomplish this objective, 121 subjects (19.2-55.4 years) were enrolled in the study, having a wide range of Hb concentrations (8.2-17.4 g/dL) obtained from two standard Laboratory analyzers. To inspect the performance, the unique dimensionality reduction approaches are applied with numerous regression models using 5-fold cross-validation. Results:: The optimum accuracy is found using support vector regression (SVR) and mutual information having 3 independent features i.e. Pearson correlation (r)= 0.79, standard deviation (SD)= 1.07 g/dL, bias=-0.13 g/dL and limits of agreement (LoA)=-2.22 to 1.97 g/dL. Additionally, comparability between two standard laboratory analyzers is found as; r=0.97, SD=0.50 g/dL, bias=0.21 g/dL, and LoA= -0.77 to 1.19 g/dL. Conclusion:: The precision of ±1 g/dL in 5-fold cross-validation ensures the same performance irrespective of different age groups, gender, BMI, smoking level, drinking level, and skin type. The outcomes with the offered NIR sensing system and an exclusive ML algorithm can accelerate its’ requirement at remote locative rural areas and critical care units where continuous Hb monitoring is compulsory.